Beyer Pat's Form 4 filing
CONMED Corp (CNMD) · filed Nov 2, 2021
- Accession no.
- 0001127602-21-028140
- Filed
- Nov 2, 2021
- Trade date
- Oct 29, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.68M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Beyer PatCIK 0001627985 | Officer (President Int'l & Global Ortho) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2021 | Common Stock | MOption exerciseAcquired | +55,300 | $39.87 | +$2,204,811 | 63,107 | Direct | |
| Oct 29, 2021 | Common Stock | FTax withholdingDisposed | −30,018 | $144.62 | −$4,341,203.16 | 33,089 | Direct | |
| Oct 29, 2021 | Common Stock | SSaleDisposed | −2,789 | $144.50F1 | −$403,010.5 | 30,300 | Direct | |
| Oct 29, 2021 | Common Stock | SSaleDisposed | −16,904 | $145.31F2 | −$2,456,320.24 | 13,396 | Direct | |
| Oct 29, 2021 | Common Stock | SSaleDisposed | −5,589 | $146.14F3 | −$816,776.46 | 7,807 | Direct | |
| Oct 29, 2021 | Common Stock | MOption exerciseAcquired | +50,700 | $51.30 | +$2,600,910 | 58,507 | Direct | |
| Oct 29, 2021 | Common Stock | FTax withholdingDisposed | −33,253 | $146.28 | −$4,864,248.84 | 25,254 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2021 | Common Stock | MOption exerciseDisposed | −55,300 | $0.00 | $0 | 0 | Direct | |
| Oct 29, 2021 | Common Stock | MOption exerciseDisposed | −50,700 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.